mepa8 Get alerts

Case report describes ECPR after remimazolam-linked anaphylaxis and cardiac arrest

Circulation returned 15 minutes after the arrest, later skin testing reacted only to remimazolam, and the patient went home on day 18 with intact neurological function.

Mepa8 headline card: Case report describes ECPR after remimazolam-linked anaphylaxis and cardiac arrest

Key takeaways

  • A case report in JA Clinical Reports describes a 69-year-old man who went into anaphylactic shock and pulseless electrical activity arrest right after remimazolam was given to induce anesthesia.
  • Conventional chest compressions did not produce adequate perfusion, so the team started venoarterial ECMO during CPR, and circulation returned 15 minutes after the arrest began.
  • The ECG showed marked ST-segment elevation during the reaction, but a coronary CT six weeks later showed normal coronary arteries, consistent with type 1 Kounis syndrome.
  • Intradermal testing nine weeks after the event was positive only for remimazolam, at 0.05 mg/mL.
  • For crews: the patient received a cumulative 6 mg of IV adrenaline during the intraoperative resuscitation and was discharged on day 18 with intact neurological function, per the summary.

A case report published in the journal JA Clinical Reports describes a 69-year-old man who developed refractory anaphylactic shock and then cardiac arrest moments after receiving the anesthetic remimazolam. Clinicians restored his circulation with extracorporeal cardiopulmonary resuscitation (ECPR). The account comes from a summary of the report that Bioengineer published on November 21, 2026 [2]. The summary does not give the date the journal article itself appeared.

The arrest happened in the operating room during induction of general anesthesia for a planned left upper lobe lung resection, according to the summary. The team suspected anaphylaxis complicated by type 1 Kounis syndrome, which the summary calls an allergic acute coronary syndrome. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was started during CPR. Spontaneous circulation returned 15 minutes after the arrest began [2].

The patient was later extubated and his heart recovered fully. He left the hospital, in the summary's words, "without any measurable neurological deficits" [2].

What the records show

The patient. The man was 169 cm tall and weighed 78.4 kg. His history included persistent atrial fibrillation, hypertension and diabetes mellitus, treated with rivaroxaban, amlodipine, vildagliptin and metformin. He reported no drug allergies, no beta-blocker use and no previous general anesthesia. More than two years earlier he had six gastrointestinal endoscopies under midazolam sedation, all without adverse events. Before surgery, his ECG showed his baseline atrial fibrillation and his echocardiogram showed preserved left ventricular function [2].

The exposure. His back was prepped with 1.0% chlorhexidine gluconate, and an epidural catheter was placed after local anesthesia with 1.0% lidocaine containing adrenaline. Induction began with a 10 mg IV bolus of remimazolam and a 60 mg/h maintenance infusion, alongside remifentanil at 0.2 µg/kg/min. Almost right away he became tachycardic and began coughing severely [2].

The collapse. Bag ventilation grew difficult because of high airway resistance. The team gave 50 mg of rocuronium and placed a 37-Fr double-lumen endotracheal tube. After intubation the monitor showed sudden, marked ST-segment elevation. Systolic pressure fell to 40 mmHg and peak airway pressures rose sharply. IV adrenaline boluses and fluids did not halt the decline, and the patient went into pulseless electrical activity arrest [2].

The resuscitation. CPR began at once, but closed-chest compressions did not generate adequate perfusion pressure, the summary says. Cannulation for VA-ECMO was done while compressions continued. Circulation returned at 15 minutes, and full circuit flow was reached two minutes thereafter. In total, 6 mg of IV adrenaline was given during the intraoperative resuscitation [2].

After ROSC. ST elevation resolved quickly. Echocardiography in the operating room showed diffuse, severe left ventricular dysfunction with no focal wall motion abnormality. A nicorandil infusion was started at 2 mg/h for suspected coronary vasospasm. After talking with cardiology, the team put off emergent coronary angiography to focus on stabilizing the patient. Cardiac markers rose only slightly, with total creatine kinase at 99 IU/L and CK-MB at 47 IU/L [2].

Tryptase. Serum tryptase was 49.5 µg/L at 45 minutes, 27.2 µg/L at 5 hours and 4.5 µg/L at 24 hours. The summary describes this as consistent with IgE-mediated anaphylaxis [2].

Recovery. ECMO was removed on hospital day 2 while the patient was on dobutamine. By day 3, ventricular function had recovered and inotropes were stopped. He was discharged home on day 18 after surgery [2].

Identifying the trigger. Allergy testing nine weeks later covered chlorhexidine, lidocaine with adrenaline, remifentanil, rocuronium and remimazolam. Every skin prick test was negative. Intradermal testing was positive only for remimazolam, at 0.05 mg/mL. A coronary CT six weeks after the arrest showed normal coronary arteries with no major stenosis. According to the summary, this supported a final diagnosis of type 1 Kounis syndrome caused by remimazolam anaphylaxis [2].

Why it matters for clinicians

In this case, anaphylaxis showed up on the monitor as ST-segment elevation and then PEA arrest. Yet imaging weeks later found no coronary disease. The summary reports that the authors classify Kounis syndrome into three types. Type 1 involves coronary spasm without preexisting coronary disease and makes up roughly 72.6% of cases, according to the summary [2].

The case also documents one use of ECPR for an arrest that did not respond to compressions, adrenaline and fluids. Here it happened in an operating room, where cannulation could start while compressions continued. The patient had tolerated midazolam sedation several times before, and he reacted only to remimazolam on intradermal testing [2].

What the records do not tell us

  • This is one patient. A single case report cannot establish how often remimazolam causes anaphylaxis or how often ECPR succeeds in this setting.
  • The packet's copy of the journal page held no article text, so this account rests on a secondary summary. The authors' names, their institution and the country where the case occurred are not given.
  • The summary does not say whether midazolam was included in the skin testing.
  • The summary's explanation of the Kounis syndrome types breaks off partway, so the authors' full discussion and conclusions are not available.
  • The records include no regulatory statement about remimazolam and no comment from its manufacturer.

Questions readers ask

Can remimazolam cause anaphylaxis?

A case report in JA Clinical Reports describes a 69-year-old man who went into anaphylactic shock and cardiac arrest right after receiving remimazolam during anesthesia induction. Intradermal testing nine weeks later was positive only for remimazolam.

What is Kounis syndrome?

The summary calls Kounis syndrome an allergic acute coronary syndrome. It reports that type 1, which involves coronary artery spasm without preexisting coronary disease, makes up about 72.6% of cases.

How was the patient resuscitated after remimazolam anaphylaxis?

Conventional CPR did not produce adequate perfusion, so the team started venoarterial ECMO while compressions continued. Circulation returned 15 minutes after the arrest, and a cumulative 6 mg of IV adrenaline was given.

Did the patient survive the remimazolam reaction?

Yes. ECMO was removed on hospital day 2, and the patient was discharged home on day 18 with intact neurological function, according to the summary.

Sources

  1. Bioengineer: Extracorporeal CPR Rescues Patient After Suspected Remimazolam-Triggered Anaphylaxis and Cardiac Arrest (Nov. 21, 2026) (2026-11-21). bioengineer.org/extracorporeal-cpr-rescues-patient-after-suspected-rem
How this story was made Drafted by Mepa8's AI newsroom from the 1 record listed above and nothing else. Before publication a verification program confirmed that every number and quotation in the story appears in those records, that no passage was copied from them, and that every cited link opens. Editor: Ryan Bolden, EMS professional, who reviews published stories and handles corrections. Medical review pending. How we use AI · Report an error

This is news, not medical advice. EMS clinicians: follow your local protocols and medical direction.

Free alerts

Know about the next recall or outbreak the day it is posted.

One email when a story touches EMS equipment, medications or public health. Plus the free 6am briefing if you want it.

Send me